Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers–Danlos contiguous gene deletion syndrome CAH-X

OBJECTIVE: Approximately 10% of patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency carry a mutation that disrupts CYP21A2 and the flanking TNXB gene resulting in CAH-X, a contiguous gene deletion syndrome. TNXB encodes tenascin-X (TNX), an extracellular matrix glycop...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolli, Vipula, Kim, Hannah, Rao, Hamsini, Lao, Qizong, Gaynor, Alison, Milner, Joshua D., Merke, Deborah P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820911/
https://www.ncbi.nlm.nih.gov/pubmed/31666125
http://dx.doi.org/10.1186/s13104-019-4753-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820911/
https://www.ncbi.nlm.nih.gov/pubmed/31666125
http://dx.doi.org/10.1186/s13104-019-4753-7

Ejemplares similares